These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34071914)

  • 1. Improved Tumor-Targeting with Peptidomimetic Analogs of Minigastrin
    Grob NM; Schibli R; Béhé M; Mindt TL
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34071914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog
    Sauter AW; Mansi R; Hassiepen U; Muller L; Panigada T; Wiehr S; Wild AM; Geistlich S; Béhé M; Rottenburger C; Wild D; Fani M
    J Nucl Med; 2019 Mar; 60(3):393-399. PubMed ID: 30002107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological inhibition of mTORC1 increases CCKBR-specific tumor uptake of radiolabeled minigastrin analogue [
    Grzmil M; Qin Y; Schleuniger C; Frank S; Imobersteg S; Blanc A; Spillmann M; Berger P; Schibli R; Behe M
    Theranostics; 2020; 10(24):10861-10873. PubMed ID: 33042258
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholecystokinin 2 Receptor Agonist
    Rottenburger C; Nicolas GP; McDougall L; Kaul F; Cachovan M; Vija AH; Schibli R; Geistlich S; Schumann A; Rau T; Glatz K; Behe M; Christ ER; Wild D
    J Nucl Med; 2020 Apr; 61(4):520-526. PubMed ID: 31519804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Response of CCKBR-Positive Tumors to Combinatory Treatment with Everolimus and the Radiolabeled Minigastrin Analogue [
    Grzmil M; Imobersteg S; Blanc A; Frank S; Schibli R; Béhé MP
    Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,5-Disubstituted 1,2,3-Triazoles as Amide Bond Isosteres Yield Novel Tumor-Targeting Minigastrin Analogs.
    Grob NM; Schibli R; Béhé M; Valverde IE; Mindt TL
    ACS Med Chem Lett; 2021 Apr; 12(4):585-592. PubMed ID: 33859799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting.
    Klingler M; Decristoforo C; Rangger C; Summer D; Foster J; Sosabowski JK; von Guggenberg E
    Theranostics; 2018; 8(11):2896-2908. PubMed ID: 29896292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.
    Klingler M; Summer D; Rangger C; Haubner R; Foster J; Sosabowski J; Decristoforo C; Virgolini I; von Guggenberg E
    J Nucl Med; 2019 Jul; 60(7):1010-1016. PubMed ID: 30530828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs.
    Zavvar TS; Hörmann AA; Klingler M; Summer D; Rangger C; Desrues L; Castel H; Gandolfo P; von Guggenberg E
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37052226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Actinium-225 Labeled Minigastrin Analogue [
    Qin Y; Imobersteg S; Blanc A; Frank S; Schibli R; Béhé MP; Grzmil M
    Pharmaceutics; 2020 Nov; 12(11):. PubMed ID: 33198403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of Radiolabeled Analogs of Minigastrin by Multiple Amide-to-Triazole Substitutions.
    Grob NM; Schmid S; Schibli R; Behe M; Mindt TL
    J Med Chem; 2020 May; 63(9):4496-4505. PubMed ID: 32302130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triazolo-Peptidomimetics: Novel Radiolabeled Minigastrin Analogs for Improved Tumor Targeting.
    Grob NM; Häussinger D; Deupi X; Schibli R; Behe M; Mindt TL
    J Med Chem; 2020 May; 63(9):4484-4495. PubMed ID: 32302139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of
    Hörmann AA; Klingler M; Rangger C; Mair C; Joosten L; Franssen GM; Laverman P; von Guggenberg E
    Pharmaceutics; 2023 Feb; 15(3):. PubMed ID: 36986657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial In Vitro and In Vivo Evaluation of a Novel CCK2R Targeting Peptide Analog Labeled with Lutetium-177.
    Hörmann AA; Klingler M; Rezaeianpour M; Hörmann N; Gust R; Shahhosseini S; Guggenberg EV
    Molecules; 2020 Oct; 25(19):. PubMed ID: 33049999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiolabeled gastrin/CCK analogs in tumor diagnosis: towards higher stability and improved tumor targeting.
    Kaloudi A; Nock BA; Krenning EP; Maina T; De Jong M
    Q J Nucl Med Mol Imaging; 2015 Sep; 59(3):287-302. PubMed ID: 26158215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [
    Rottenburger C; Hentschel M; Fürstner M; McDougall L; Kottoros D; Kaul F; Mansi R; Fani M; Vija AH; Schibli R; Geistlich S; Behe M; Christ ER; Wild D
    EJNMMI Res; 2024 Apr; 14(1):37. PubMed ID: 38581480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of d-glutamine and d-glutamic acid sequences in optical peptide probes targeted against the cholecystokinin-2/gastrin-receptor on binding affinity, specificity and pharmacokinetic properties.
    Kossatz S; Mansi R; Béhé M; Czerney P; Hilger I
    EJNMMI Res; 2013 Nov; 3(1):75. PubMed ID: 24238262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the First
    Günther T; Holzleitner N; Di Carlo D; Urtz-Urban N; Lapa C; Wester HJ
    Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling Network Response to α-Particle-Targeted Therapy with the
    Qin Y; Imobersteg S; Frank S; Blanc A; Chiorazzo T; Berger P; Schibli R; Béhé MP; Grzmil M
    J Nucl Med; 2023 Jun; 64(6):873-879. PubMed ID: 36732057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.
    Klingler M; Rangger C; Summer D; Kaeopookum P; Decristoforo C; von Guggenberg E
    Pharmaceuticals (Basel); 2019 Jan; 12(1):. PubMed ID: 30650563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.